Alfuzosin hydrochloride

Cat. No.: 0225LY-1210

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Alfuzosin hydrochloride serves as an alpha-1 adrenergic receptor antagonist indicated for the management of benign prostatic hyperplasia (BPH).

Synonym: SL 77499-10; Alfuzosin HCl; 81403-68-1; Uroxatral; Urion; Alfoten; Xatral; Alfuzosin (hydrochloride); SL 77 499-10; N-(3-((4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino)propyl)tetrahydrofuran-2-carboxamide hydrochloride; (+-)-N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furamide monohydrochloride; N-[3-[(4-amino-6,7-dimethoxy-2-quinazolinyl)methylamino]propyl]tetrahydro-2-furancarboxamide, monohydrochloride; N-(3-((4-amino-6,7-dimethoxyquinazolin-2-yl)

CAS No.: 81403-68-1

Compound CID: 71764

Formula: C₁₉H₂₇N₅O₄·HCl

Formula Weight: 425.91

Specification

Relative Density: 1.272 g/cm³

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Alfuzosin hydrochloride can be used in urological research to study the selective antagonism of alpha-1 adrenergic receptors in the lower urinary tract.